It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments ... and established prescription products.

Zucara Therapeutics Inc., ("Zucara" or the "Company") a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

Fitch Solutions has predicted that the naira would slide to as low as N1,993 per dollar in 2028, severely impacting Nigeria’s ...

The PEGylated Proteins Market is primarily driven by the growing demand for effective drug delivery systems, particularly in the treatment of chronic diseases such as cancer, hepatitis, and rheumatoid ...

Fitch Solutions, a financial intelligence service provider, has predicted that the Naira would depreciate to N1,993 per USdollar by 2028.

Ruxandra brings more than 20 years of extensive clinical, corporate and global public health expertise to ... We believe that ...

It marks a significant change in direction for Ipsen, which has spent several years of building up the consumer health business through the acquisition of products from Sanofi, Boehringer ...

The third new business unit – emerging markets – bundles Sanofi's generic medicines and older products still in patent with the company's consumer healthcare products, emphasising that in ...